Back
Results - Announcements
Sales rise 13.49% to Rs 166.32 crore
Lincoln Pharmaceuticals consolidated net profit rises 37.70% in the December 2025 quarter
12-Feb-2026, 01:00
Net profit of Lincoln Pharmaceuticals rose 37.70% to Rs 28.60 crore in the quarter ended December 2025 as against Rs 20.77 crore during the previous quarter ended December 2024. Sales rose 13.49% to Rs 166.32 crore in the quarter ended December 2025 as against Rs 146.55 crore during the previous quarter ended December 2024.
Net profit of Lincoln Pharmaceuticals rose 37.70% to Rs 28.60 crore in the quarter ended December 2025 as against Rs 20.77 crore during the previous quarter ended December 2024. Sales rose 13.49% to Rs 166.32 crore in the quarter ended December 2025 as against Rs 146.55 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 166.32 | 146.55 | 13 |
| OPM % | 14.18 | 16.14 | - |
| PBDT | 38.44 | 31.91 | 20 |
| PBT | 34.72 | 28.68 | 21 |
| NP | 28.60 | 20.77 | 38 |
Powered by Capital Market - Live News